Annie Rasmussen
Directeur/Membre du Conseil chez North Star Group A/S
Postes actifs de Annie Rasmussen
Sociétés | Poste | Début | Fin |
---|---|---|---|
North Star Group A/S | Directeur/Membre du Conseil | - | - |
Historique de carrière de Annie Rasmussen
Anciens postes connus de Annie Rasmussen
Sociétés | Poste | Début | Fin |
---|---|---|---|
TOPOTARGET A/S | Fondateur | 01/01/2000 | 01/01/2008 |
Corporate Officer/Principal | 01/01/2000 | 01/01/2008 | |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Corporate Officer/Principal | - | - |
Danish Oncology Nursing Society | President | - | - |
SCANDION ONCOLOGY A/S | Directeur/Membre du Conseil | 01/01/2020 | - |
Directeur Technique/Scientifique/R&D | 01/01/2020 | - | |
Cancer Guides Denmark
Cancer Guides Denmark Hospital/Nursing ManagementHealth Services Cancer Guides Denmark operates a hospital for cancer treatment. The private company is based in Hellerup, Denmark. The Danish company was founded by Annie Rasmussen. | Fondateur | 01/01/2009 | - |
Health Creation Denmark | Fondateur | 01/01/2007 | - |
Medical Prognosis Institute A/S
Medical Prognosis Institute A/S BiotechnologyHealth Technology Medical Prognosis Institute A/S engages in the research and development of drugs and treatments for cancer and other related illnesses. It operates through the following segments: X Labs, Predict, Ventures, Personal, and Diagnostic business areas. The X Labs business area offers invent, prototype, and prove relevant techniques, scientific methodologies and business models. The Predict business area utilize the method to generate drug and patient response reports. The Ventures business area focuses on business development ventures. The Personal business area engages in developing business to consumer products and services. The Diagnostic business area operates lung chip diagnostics. The company was founded by Steen Knudsen in September 2004 and is headquartered in Horsholm, Denmark. | Directeur Technique/Scientifique/R&D | - | - |
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Corporate Officer/Principal | 04/06/2015 | - |
Statistiques
Internationale
Danemark | 10 |
Opérationnelle
Corporate Officer/Principal | 3 |
Founder | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Sectorielle
Health Technology | 6 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SCANDION ONCOLOGY A/S | Health Technology |
Entreprise privées | 8 |
---|---|
Topotarget A/S
Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
Medical Prognosis Institute A/S
Medical Prognosis Institute A/S BiotechnologyHealth Technology Medical Prognosis Institute A/S engages in the research and development of drugs and treatments for cancer and other related illnesses. It operates through the following segments: X Labs, Predict, Ventures, Personal, and Diagnostic business areas. The X Labs business area offers invent, prototype, and prove relevant techniques, scientific methodologies and business models. The Predict business area utilize the method to generate drug and patient response reports. The Ventures business area focuses on business development ventures. The Personal business area engages in developing business to consumer products and services. The Diagnostic business area operates lung chip diagnostics. The company was founded by Steen Knudsen in September 2004 and is headquartered in Horsholm, Denmark. | Health Technology |
Oncology Venture Sweden AB
Oncology Venture Sweden AB BiotechnologyHealth Technology Oncology Venture Sweden AB engages in research and development of anti-cancer drugs through its subsidiary Oncology Ventures ApS. It focuses on diagnostics and development of medicinal products for treatment of cancer. The company was founded by Peter Buhl Jensen, Steen Meier Knudsen, Nils Aage Brünner, and Ulla Hald Buhl on June 4, 2015 and is headquartered in Hørsholm, Denmark. | Health Technology |
Health Creation Denmark | |
Cancer Guides Denmark
Cancer Guides Denmark Hospital/Nursing ManagementHealth Services Cancer Guides Denmark operates a hospital for cancer treatment. The private company is based in Hellerup, Denmark. The Danish company was founded by Annie Rasmussen. | Health Services |
Allarity Therapeutics A/S
Allarity Therapeutics A/S Pharmaceuticals: MajorHealth Technology Allarity Therapeutics A/S is a biotechnology company, which engages in the research and development of anti-cancer drugs. Its product pipeline includes LiPlaCis, 2X-121, 2X-111, irofulven phase 2, and APO010.The company was founded by Steen Meier Knudsen and Peter Buhl Jensen in 2004 and is headquartered in Hoersholm, Denmark. | Health Technology |
North Star Group A/S | |
Danish Oncology Nursing Society |
- Bourse
- Insiders
- Annie Rasmussen
- Expérience